KevinM
Senior member
- Joined
- Mar 30, 2019
- Messages
- 559
- Reason
- PALS
- Diagnosis
- 06/2019
- Country
- US
- State
- FL
- City
- Tallahassee
Hi everyone. I was looking at the ongoing and soon-to-begin clinical trials, and was certainly impressed by the number of proposed treatments being evaluated.
I was wondering if anyone here with a much deeper knowledge of biochemistry and who may have done a much more in-depth evaluation of the various treatments and early test results has an opinion on whether any therapy to treat sporadic ALS stands out to you as holding more promise. There seems to be several very exciting therapies moving forward for familial ALS, but sporadic ALS appears to be a much more challenging nut to crack in many ways.
I am not asking this so that I can rush to enroll, though I understand the argument that participating an any trial helps further research whether or not the treatment proves effective. I’m just looking for any reason to feel mildly optimistic.
We all know about AMX0035, CuATSM, and NurOwn, but there are so many other trials that I get lost trying to evaluate their potential. I’m very aware that early results can be misleading and most will fail on either safety, efficacy, or both, but I’d love to hear anyone’s thoughts. Thanks, Kevin
I was wondering if anyone here with a much deeper knowledge of biochemistry and who may have done a much more in-depth evaluation of the various treatments and early test results has an opinion on whether any therapy to treat sporadic ALS stands out to you as holding more promise. There seems to be several very exciting therapies moving forward for familial ALS, but sporadic ALS appears to be a much more challenging nut to crack in many ways.
I am not asking this so that I can rush to enroll, though I understand the argument that participating an any trial helps further research whether or not the treatment proves effective. I’m just looking for any reason to feel mildly optimistic.
We all know about AMX0035, CuATSM, and NurOwn, but there are so many other trials that I get lost trying to evaluate their potential. I’m very aware that early results can be misleading and most will fail on either safety, efficacy, or both, but I’d love to hear anyone’s thoughts. Thanks, Kevin